NCT00154167View on ClinicalTrials.gov

Safety and Efficacy Study of NV-101 in Dental Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

February 28, 2003

Study Completion Date

June 30, 2003

Conditions
Soft Tissue Anesthesia (Numbness)
Interventions
DRUG

NV-101 (phentolamine mesylate solution)

Trial Locations (1)

98403

Northwest Kinetics, Tacoma

Sponsors
All Listed Sponsors
lead

Novalar Pharmaceuticals, Inc.

INDUSTRY